The Disposable Sterile Thoracentesis Kit market is principally divided by application, reflecting the clinical intent of pleural fluid removal. Diagnostic kits are employed when thoracentesis serves to obtain fluid for laboratory analysis, infection screening, or cytology. This segment accounts for roughly 55 % of total revenue because hospitals and diagnostic centers perform high‑volume procedures for disease staging and differential diagnosis, driving repeat purchases of standardized, cost‑effective kits. Therapeutic kits, representing about 45 % of the market, are used to alleviate symptomatic pleural effusions, pneumothorax, or hemothorax, where rapid drainage is critical. These procedures often require kits with larger volume capacity and integrated suction accessories, leading to higher unit pricing. The Disposable Sterile Thoracentesis Kit segmentation by application therefore mirrors the balance between routine diagnostic sampling and acute therapeutic drainage, each contributing proportionally to overall market size through distinct procurement patterns and price points. Furthermore, reimbursement policies differ between the two groups, with diagnostic procedures often covered under laboratory codes, while therapeutic interventions are billed under procedural tariffs, reinforcing the observed revenue split.
